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Abstract
Background: In experimentally induced puromycine aminonucleoside nephrosis (PAN) animal models, nephrotic
syndrome with minimal change disease and focal and segmental sclerosis-like nephritis similar to that in human is
demonstrated; however, the real mechanism of PAN is not yet elucidated. Platelet derived endothelial cell growth
factor (PD-ECGF), an endothelial mitogen protein, is believed to take part in microvessel formation and in
stimulation of angiogenesis and its expression has not been totally demonstrated in PAN rats yet. In this study, we
aimed to examine PD-ECGF expression in acute and chronic PAN induced in rats and find out the association
between its expression and the stages of angiogenesis in kidney.
Methods: For the experiment, twenty-four Male Wistar Albino rats were used and divided into four groups; control
group (n = 6), pre-proteinuria group (n = 6), acute group (n = 6) and chronic group (n = 6). We compared
statistically all data by One-way ANOVA Test followed by Dunn Multiple Comparison Test.
Results: Proteinurea levels in control and pre-proteinuria groups were not statistically different; however, it was
remarkably higher in the acute nephrosis group and significantly greater in the chronic nephrosis group than
control group (p < 0.0025). In pre-proteinuria group, the serum albumin and creatinine clearances also did not
significantly differ from the control group. On the other hand, in the acute and chronic nephrosis groups, serum
albumin and creatinine clearances progressively decreased (p < 0.05). In our immunohistochemical studies, we
showed elevated PD-ECGF expression in glomeruli of acute and chronic PAN rats. Microscopic and ultrastructural
appearances of the glomeruli of acute and chronic PAN showed various sequential steps of angiogenesis,
macrophages and immature capillaries with primitive lumens and apoptotic endothelial cells in the increased
mesangial matrix.
Conclusions: It is reported that acute and chronic PAN progressively increase PD-ECGF expression and following
induction of angiogenesis in the affected glomeruli.
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Experimentally induced puromycine aminonucleoside
nephrosis (PAN), generally used as a model for podocyte
injury, has the increase of mesangial matrix in glomeruli
leading to massive proteinuria. It has been similar to the
effects of minimal change disease and focal and segmen-
tal sclerosis-like nephritis in human [1-7]. However, the
real mechanism of PAN is not yet elucidated.
Platelet derived endothelial cell growth factor (PD-
ECGF/thymidine phosphorylase), isolated as an endothe-
lial mitogen from platelets, is a 45-kDa angiogenic protein
which stimulates the growth and chemotaxis of endothe-
lial cells in vitro and angiogenesis in vivo [8-16]. Various
studies have shown that PD-ECGF is one of the potent
promoters of angiogenesis and mediates angiogenesis dur-
ing many physiological and pathophysiological processes.
Main sources of PD-ECGF are the infiltrating cells and
especially macrophages, however, the mechanisms by
which PD-ECGF contributes to angiogenesis are still
unclear [8,10,17-21]. PD-ECGF is also expressed in the
endothelium of various tissues [22].
It was reported that PD-ECGF expression is elevated in
areas of interstitial fibrosis in scarred kidneys because
local oxygen supply is most likely to be diminished in
these areas due to obliteration of the postglomerular capil-
lary network, tubules and fibroblasts and that its level of
expression is correlated with the number of microvessels
in various pathological conditions [17,20,22-24]. More-
over, experimental and clinicopathological studies have
shown that the losses of podocytes [25] and renal capil-
laries [26] causing reduction of oxygen and nutritional
supply to the kidney are closely linked with chronic dis-
ease progression and renal scarring. As known, hypoxia is
a common stimulus for both angiogenesis and inflamma-
tion leading to the accumulation of macrophages and
other immune cells [27], and for increased production of
growth factors [28-31].
In this study, it was aimed to investigate PD-ECGF
expression and angiogenesis in the glomeruli of acute and
chronic puromycine aminonucleoside (PA) induced
nephrotic rats with the view of the fact that hypoxia which
might be developed due to loss of existing capillaries
within the mesangial matrix may cause angiogenesis.
Methods
Preparation of Animals
Twenty-four young male Wistar albino rats weighing 90-
120 g (Experimental Animals Reproduction and Research
Laboratory, Istanbul University Cerrahpasa Medical
Faculty, Turkey) were housed in individual cages in a
temperature- and humidity- controlled room with a 12-h
light/dark cycle. They were fed with standard rat chow
and had free access to tap water.
Rats were divided into four groups with one control and
three experimental groups (n = 6). The injection amounts,
intervals and sacrification days are given in Table 1. Group
I served as control and begining from the second day, con-
trol group was daily injected by 1 ml isotonic sodium
chloride. Control rats were sacrificed at 10
th day. Three
experimental groups were daily injected by 1.67 mg puro-
mycine aminonucleoside (PA) (Sigma Chemical Co St.
Louis, MO, USA) per 100 g body weight in 1 ml isotonic
sodium chloride subcutaneously. Proteinuria developed in
all PA injected rats at 6th day after the 5th injection.
According to these parameters, we constituted two experi-
mental groups. Group II, the “pre-proteinuria group”, was
killed on day 4 after 3th injection. Group III, the “acute
nephrosis group”, was sacrified on day 10 after 9th injec-
tion. The group IV, “chronic group”, was created as
described by Marinides (1990). Group IV rats received the
same dose of PA once a week in the first three weeks,
once in two weeks in the following weeks subcutaneously
and they were killed after the 7th injection in 12 weeks
(See Table 1). All rats were sacrified under ether anesthe-
sia at the end of the study according to the regulation of
animal ethical committee of Istanbul University.
The urine sample of each rat was daily collected and
protein level was measured using the modified trichlorace-
tyl acid (TCA) method [32]. All animals were weighed and
their blood samples were taken for measurement of serum
albumin and creatinine values (Jaffe) [20] (Table 2). Serum
albumin levels were measured in clinical chemistry analy-
zer (Architect C8000, Abbott, Illinois, USA) using reagents
purchased by the same manufacturer.
Light and electron microscopical analyses
After necropsy, the left kidney cortex was immediately
divided into 1 mm3 pieces for transmission electron
microscopy. They were firstly fixed in 4% glutaraldehyde
(Sigma, G5882, USA) in a 0.1 M phosphate buffer solu-
tion (PBS), post-fixed by 1% OsO4 prepared in the same
buffer solution, dehydrated with graded ethanol (Merck,
Germany) and, embedded into araldite medium (G4901
Sigma Chemical Co St. Louis, MO, USA). Semi-thin sec-
tions were cut into 1 μm thickness by glass knives to help
of the ultramicrotome (Reichert UM 2 and UM 3, Aus-
tria) and stained with 1% toluidine blue (prepared with
1% borax in bidistilled water). The sections were exam-
ined under a binocular light microscope (Leica, Ger-
many) using immersion objective. Ultra-thin sections
were obtained in 50 nm thickness onto copper grids (300
mesh) with the same microtome, stained with uranyl
acetate and lead citrate and they were investigated by
transmission electron microscope (Zeiss Electron Micro-
scope 9 and Electron Microscope 10, Oberkochen,
Germany).
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Cortical renal tissues were fixed in 10% neutral buffered
formalin and embedded in paraffin. For detection of
angiogenesis, TP/PD-ECGF (Thymidine Phosphorylase/
Platelet Derived-Endothelial Cell Growth Factor) protein
immunohistochemical staining was performed. The sec-
tions of 5 μm thickness were placed onto slides coated
with poly-L-Lysine, (PLL, Sigma, St. Louis, MO) then
deparaffinized in toluene and rehydrated in graded alcohol
series. Histostain-Plus™ Broad Spectrum Kit (95-9943-B
Zymed Lab. Ins. San Francisco CA, USA) was used for
immunoperoxidase staining. Immunohistochemistry pro-
cedure was performed using a combination of microwave
oven heating for antigen retrieval and standard streptavi-
din-biotin-peroxidase method. Endogenous peroxidase
activity was blocked by hydrogen peroxide (3%). Each sec-
tion was then incubated for 15 minutes at room tempera-
ture with blocking solution to block cellular peroxidase
activity. Sections were incubated with anti-TP/PD-ECGF
antibody (host range: human, mouse, rat; prediluted; Lab-
Vision Corp., USA) for 1 hour at room temperature, then
washed with PBS. Specific staining was performed with
biotinlated universal secondary antibody, horseradish per-
oxidase streptavidin-complex, and amino-ethyl-carbazole
as chromogen. Sections were counter-stained with Mayer’s
hematoxylin. As for negative control, distilled water was
performed instead of primary antibody and as positive
control, a malignant melanoma tissue was used.
Semi-quantitation of immunoperoxidase staining
PD-ECGF immunperoxidase reaction of the rats’ glo-
meruli was evaluated by Hill’s scoring system [33].
This evaluation has been done by two observers in all
rats of each group in at least randomly chosen ten glo-
meruli in two different sections of same tissue and all
values were summed in Table 4. Immunopositivity was
s c o r e df r o m0t o+ 4( 0=n o n e ,+ 1w e a ki m m u n o p o s i -
tivity, +2 moderate immunopositivity, +3 strong immu-
nopositivity and +4 very strong immunopositivity)
(Table 4).
Statistical Analysis of Total Angiogenic Stages
All stages of angiogenic fields are counted in 10 ran-
domly selected glomerules of all groups in semi-thin
sections (stained with toluidine blue) by two observers
under light microscope (Olympus BX61) with 100x
immersion objective. Averages of data are given in
Table 5 as mean and standart deviation (median) and
compared by One-way ANOVA followed by Dunn Mul-
tiple Comparison Test. In all comparisons, statistical sig-
nificance was defined as p < 0.01.
Statistical Analysis of Urine and Blood Data
Proteinuria, serum albumin, creatinine-clearance, weight
data of all groups were given as mean ± standard devia-
tion (median) and compared by Kruskal Wallis ANOVA
followed by Dunn Multiple Comparison Test. In all
Table 1 Injection intervals and amounts of all groups
Groups Injection Intervals Injection Amount Total Injection
Number
Sacrification
day
Group I: Control Daily 1 ml isotonic NaCl 9 10
th day
Group II: Pre-
proteinurea
Daily 1.67 mg PA per 100 g body weight in 1 ml
isotonic NaCl
34
th day
Group III: Acute
Nephrosis
Daily 1.67 mg PA per 100 g body weight in 1 ml
isotonic NaCl
91 0
th day
Group IV: Chronic Weekly in first 3 weeks Biweekly in the
rest weeks
1.67 mg PA per 100 g body weight in 1 ml
isotonic NaCl
71 2
th week
Table 2 All groups: Proteinuria, Serum Albumin, Creatinine -Clearance, Weight
Groups Proteinuria mg/24 hours Serum Albumin g/dl Creatinin-Cl. ml/min Weight g
Control At start 3.12 ± 2.40 105 ± 13.78
Last 4.87 ± 3 3.23 ± 0.10 0.55 ± 0.80 140 ± 15.49
Pre-Proteinuria At start > 3. inj. 4.59 ± 3.70 100 ± 15.80
5.57 ± 2 3.02 ± 0.15 0.49 ± 0.80
Acute Nephrosis At start > 9.inj. 5.04 ± 2 101 ± 0.80
91.34 ± 91* 2.50 ± 0.63** 0.38 ± 0.28**
Chronic Nephrosis At start > 7.inj. 5.18 ± 2.20 100 ± 8.94
247.5 ± 90* 2.35 ± 0.38** 0.29 ± 0.10** 210 ± 24.49**
All data are presented as mean ± SD (median) and analyzed by Dunn Multiple Comparison Test following Kruskal Wallis ANOVA.
*p < 0.0025 **p < 0.05
For all groups their own control protein excretion (at start) is shown.
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0.05 and p < 0.0025 (Table 4).
Results
Urine and blood analyses
In control and experimental groups, proteinuria (mg/24
hours), serum albumin (g/dl), creatinine clearance (ml/
minute) and weight (g) are shown in Table 2. In all
PAN induced rats, proteinuria increased suddenly and
significantly after the fifth injection (6th day). The ‘pre-
proteinuria group’ was just defined as the group two
days before this rising of proteinuria (see Table 3). As it
is shown in Table 2, proteinuria levels in control and
pre-proteinuria group were not significantly different
from each other (p < 0.0025). Their serum albumin,
creatinine clearances and weights also were not signifi-
cantly different (p < 0.05). However, proteinuria in the
acute group significantly increased. Serum albumin and
creatinine clearances significantly decreased.
In the chronic nephrosis group, proteinuria was
remarkably higher than it was in the acute group and
about significantly higher than it was in the controls
(p < 0.0025). Serum albumin decreased significantly and
creatinine clearance decreased to nearly half of that in
the control group (p < 0.05) and it was accepted as an
evidence of glomerulopathology. In the rats of the
chronic group, body weight rise to the two-fold of that
in the controls due to the increase in fluid resorption
(p < 0.05) (Table 2).
Immunohistochemistry
There was no immunreaction for PD-ECGF in the control
group animals (Figure 1A) and negative control prepara-
tions (Figure 1E). In the pre-proteinuria group, a weak
immunpositivity was detected (Figure 1B). The acute and
chronic nephrosis groups showed a strong immunpositiv-
ity especially in the cells of mesangial matrix regions
(Figure 1C, D; Table 4). Pozitive control (malignant mela-
noma) showed strong positivity (Figure F).
Light microscopy
In the acute and chronic group animals’ glomeruli, dilation
of existing capillaries with endothelial proliferation and
expanded mesangial matrix were observed. Within the
expanded mesangial matrix, loss of existing capillaries was
generally observed while angiogenic cell groups containing
bigger nuclei with peripherally located heterochromatin
(Figure 2A, B) and immature capillaries which have
endothelial cells with dense basophilic cytoplasm at the
polarization stage (Figure 2C, D) were seen. In advanced
lumen formation stage of polarization of immature capil-
laries, their endothelial cells were differentiated and their
cytoplasm contained numerous vacuoles (Figure 2D).
Immature capillaries were generally observed in adjacent
Table 3 Values of Proteinuria in acute nephrosis group/1-9. injections
Rats Proteinuria (mg/24 hours)
Before inj. 1.inj. 2.inj. 3.inj. 4.inj. 5.inj.
a 6.inj. 7.inj. 8.inj. 9. inj.
1
st 5.30 5.80 5.50 6.55 11.37 17.42 15.24 19.82 27.74 47.52
2
nd 3.39 4.62 6.43 8.22 11.32 14.35 18.52 17.68 24.22 41.55
3
rd 7.18 6.31 6.72 9.96 16.32 15.68 12.69 17.36 30.20 131.90
4
th 4.64 4.25 3.80 4.87 8.03 12.59 14.28 18.04 25.67 76.53
5
th 4.58 4.20 4.67 6.46 6.41 12.56 19.67 26.95 33.16 67.91
6
th 5.19 4.29 4.40 4.39 12.81 15.03 12.28 23.42 76.45 183.67
Average 5.04 4.91 5.25 6.74 11.04 14.60 15.44 20.50 36.24 91.34
Standard dev. ± 2 ± 1.4 ± 1.4 ± 3.2 ± 5.2 ± 2.8 ± 4.2 ± 6.4 ± 40 ± 91
a. Proteinuria increased after the 5rd injection
Table 4 In all groups, number of cases and
immunostaining for PD-ECGF
Groups (n = 6) Number of Cases PD-ECGF
Control 6/6 -
Pre-Proteinuria 5/6 +
Acute nephrosis 4/6 ++
Chronic nephrosis 5/6 ++++
Immunpositivity is scored from 0 to 4 as (-none-, +1 weak immunpositivity, +2
moderate immunpositivity, + 3 strong immunpositivity, +4 very strong
immunpositivity).
Table 5 Total angiogenic stage counts in all groups
Groups (n = 6) Average angiogenic stage counts in 10
glomerules
Control 0.12 ± 0.04
Pre-Proteinuria 1.08 ± 0.03**
Acute nephrosis 2.13 ± 0.14**
Chronic
nephrosis
4.87 ± 0.21**
All data are presented as mean ± SD (median) and analyzed by Dunn Multiple
Comparisons Test following One-way ANOVA.
**p < 0.01
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like type macrophages’ (Figure 2E).
When total angiogenic stages of semi-thin sections
were counted under light microscope in 10 glomeruli of
each rat in all groups, mean values showed that angioge-
netic stage numbers of pre-proteinurea, acute and
chronic nephrosis groups were significantly different
from control group and showed gradually increasing
manner in experimental groups (Table 5).
Electron microscopy
In the expanded mesangial matrix of the glomeruli in acute
and chronic PAN, there was generally loss of existing capil-
laries but we showed the angiogenic cell islands without
basal lamina and lumen (Figure 3A) and immature capil-
laries (Figure 3B-F). Angiogenic cells have big nuclei with
peripherally located heterochromatin (Figure 3A). Further-
more, in some areas of acute and chronic PAN glomeruli,
primitive lumen formation stages of polarization were
observed in immature capillaries (Figure 3B-F). In these
immature capillaries, endothelial cells were also differen-
tiated (Figure 3B-F). We also observed basal lamina forma-
tion at the advanced polarization stage of immature
capillaries (Figure 3E, F). In primitive lumen development
stages of immature capillaries, endothelial cells had well
developed GER cisterns and Golgi apparatus (Figure 3C,
D). Moreover, in the advanced lumen formation stage of
immature capillaries, we observed apoptotic endothelial
cells (Figure 3E). There were macrophages in the close
proximity of these immature capillaries. Some of these
macrophages were ‘foam-cell-like’ type (Figure 3F).
Discussion
Angiogenesis, the formation of new blood vessels from
pre-existing vessels, is not only a critical step in embryo-
genesis and wound healing, but also contributes to the
pathogenesis of tumor growth and chronic inflammation
[8,10,21,23,24]. It is a complex process involving exten-
sive interaction between the cells, soluble factors and
extracellular matrix (ECM) components. Angiogenesis is
initiated by vasodilatation and increased permeability.
The formation of a vascular network requires different
sequential steps including; the release of proteases from
activated endothelial cells, degradation of the basement
membrane surrounding the existing vessels, differentia-
tion and migration of the endothelial cells into the inter-
stitial space, endothelial cell proliferation forming tubular
structures, lumen formation, generation of new basement
membrane with the recruitment of pericytes and finally
of fusion of newly formed vessels and initiation of blood
flow [18,34-39].
As it is well known, hypoxia results in both angiogen-
esis and inflammation [27], and thus the production of
growth factors increases [28-31]. Angiogenesis provides
oxygen and nutrients for the metabolic needs of the cells
that are present at inflammatory sites [18]. Therefore, we
considered that the expanded avascular mesangial matrix
regions of the glomeruli could induce the angiogenesis by
creating a hypoxic state.
In our microscopic examinations, we observed an
increased mesangial matrix with inflammatory areas
Figure 1 Expression of PDECGF in the control and
experimental groups. Control group has no immunopositivity (A).
Pre-proteinuria group has weak immunopositivity around the
mesangial matrix (B). Acute group has moderate immunopositivity
around the mesangial matrix regions (C). Chronic group has very
strong immunopositivity in the cells of mesangial matrix regions (D).
PDECGF- Negative chronic control group has no pozitivity (E) X40.
Pozitive control is malignant melanoma tissue and has strong
immunpozitivity in stromal cells (F) X20.
Figure 2 (A) In an early stage of angiogenesis, an angiogenic
cell island (circle) in the glomerulus without a basal lamina
and lumen is seen in the semi-thin section of the acute group.
X100. (B) In an early stage of angiogenesis, angiogenic cell islands
(circles) in the expanded mesangial matrix of the glomeruli are seen
in the semi thin section of the chronic group. X100. (C) In the early
polarization stage of angiogenesis, two immature capillaries (circles)
located inside an expanded dense mesangial matrix of a glomerulus
are seen in the semi thin section of the chronic group. Endothelial
cells have dense basophilic cytoplasms. X100. (D) In lumen
formation stage of angiogenesis, an immature capillary (circle) in an
expanded dense mesangial matrix with several vacuoles inside the
dense basophilic endothelial cytoplasm is shown in the semi thin
section of chronic group glomeruli. X100. (E) In the semi thin
section of the chronic group’s glomeruli, many macrophages (five
ended stars), and immature capillaries (circles) in advanced stage of
lumen (four ended stars) formation are seen. X100.
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enlarged mesangial matrix (MM) during early stage of angiogenesis. Lumen and basal lamina are not seen yet at the cell island. X2000. (B)
Immature capillary (hearth-shaped) with a primitive lumen (star) and a macrophage (MA) in an increased mesangial matrix (MM) adherent to
existing capillaries (CL), PAG: protein absorption granules in podocyte (PO), PL: Parietal layer. x2470. (C) A glomeruli area of the acute group that
shows an immature capillary (circle) in primitive lumen formation stage. A primitive lumen formation (arrow) is observed in the cell island. The
enlarged granular endoplasmic reticulum (GER) cisterns and well developed Golgi apparatus (GA) are seen in the endothelial cell’s cytoplasm
(shown with high magnification in the inset at the upper left x25000). Around immature capillary, a basal lamina can not be seen yet. N:
Nucleus. X5000. (D) An area from a glomerulus of the chronic group that shows an immature capillary (circle) in subsequent stage of primitive
lumen (stars) formation.x7500 In their cytoplasm, developed granular endoplasmic reticulum cisterns (GER) are seen in the inset at the upper left.
X25000. (E) An area from a glomerulus of the acute group that shows an immature capillary (circle) containing an advanced stage of the lumen
(stars) with an apoptotic endothelial cell and cell debris. In the periphery of the immature capillary, the basement membrane (arrows) becomes
clear. PO: Podocyte, E: Apoptotic Endothelial cell nucleus, PAG: Protein Absorption Granule × 7500. (F) An area from a glomerulus of the chronic
group that shows two small immature capillaries at the lumen formation stage (circle) and a foam-cell like macrophage (Ma) nearby. X5400.
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esis including vasodilatation and endothelial prolifera-
tion in pre-existing capillaries, as well as, angiogenic cell
islands without basal lamina and lumen formation in
immature capillaries containing basal lamina in glomer-
uli of acute and chronic PAN nephrotic rats. During
angiogenesis, the transport of plasma proteins such as
fibrinogen and plasminogen from the blood stream into
the surrounding tissue is excessively increased. These
plasma proteins provide a convenient environment for
the migrating angiogenic cells [35]. In our light micro-
scopic studies, we observed angiogenic cell islands and
immature capillaries surrounded by dense mesangial
matrix areas. We considered that this situation could be
correlated with highly concentrated plasma proteins
leaked out the pre-existing dilated capillaries around
this area.
The angiogenic cell islands can be easily distinguished
from the surrounding cells by their big nuclei with per-
ipherally located heterochromatin. These cell islands had
no basal lamina yet. When the lumen formation of angio-
genic cell islands were completed after the polarization
stage, the basal lumina has appeared [40]. As evidence to
this argument, in our microscopic and ultrastructural
images, we observed more basophilic cytoplasm of imma-
ture capillaries and prominent increase in the granular
endoplasmic reticulum cisterns which is responsible for
the formation of the basal lamina components. Moreover,
some researchers have argued that endothelial apoptosis
is effective on the primitive lumen formation stage of the
angiogenic cell islands [40]. In our study, we observed
apoptotic endothelial cells with advanced lumen forma-
tion of immature capillaries in our ultrastructural images
as a support this argument.
In our microscopic and ultrastructural images, macro-
phages were the most abundant cell type in the angiogenic
regions of the increased avascular matrix. Various cell
types and cell products induce or modulate angiogenesis.
The major of these cells are macrophages. In all steps of
angiogenesis, macrophages take place by their secretary
activity. It was reported that they had angiogenic charac-
teristics when exposed to low oxygen supply [8]. Macro-
phages are among the main sources of metalloproteases
(e.g. collagenases) and serine proteases (e.g. elastase and
plasminogen activator). These enzymes can degrade ECM
molecules, modulate the mechanical framework, and lead
to the released ECM-bound growth factors. In addition to
proteases, macrophages produce several factors that
induce migration of endothelial cells. Most of them also
support other stages of the angiogenic process such as
proliferation or differentiation of endothelial cells. Their
inducing effects on migration seem to be sufficient for the
initial neovascularization as migrating endothelial cells can
form sprouts without proliferation. Thus, macrophages
release several factors that do not directly induce angio-
genesis but act indirectly by attracting or activating angio-
genic cells. This activity occurs in all phase of the
angiogenic process [8,18,41]. Hence we considered that
the macrophages in this increased avascular matrix were
activated due to the presence of insufficient oxygen and
induced the angiogenesis.
We also showed the existence of the foam cells in the
expanded avascular mesangial matrix of glomeruli in PAN
rats. In some diseases, e.g. focal and segmental glomerulo-
sclerosis and hyalinosis, mesangial cells (MCs) exhibit
foam cell like morphology. These lipid-laden MCs have
impaired phagocytic capacity and disrupted cytoskeletons.
Studies have demonstrated that IGF-1 (insulin-like growth
factor-1) induces MC to transform into foam cell by pha-
gocytosing lipids [42,43]. We considered that these cells
frequently observed around the angiogenic regions could
be also responsible from the development of angiogenesis
like the other macrophages.
In scarred kidneys, it was reported that PD-ECGF
expression is elevated and its level of expression is corre-
lated with pathological angiogenesis [17,20,22-24]. In this
study, we detected occasional angiogenic regions in
expanded avascular mesangial matrix of the glomeruli in
acute and chronic PAN induced rats. We showed elevated
PD-ECGF immunostaining in the glomeruli of acute and
chronic PAN induced rats. When we compared control
and experimental groups, number of total angiogenic
stages in experimental groups increased in parallel with
PD-ECGF immuno-reactivity results (Table 4, 5). These
results supported our ultrastructural findings observation
related to angiogenesis development. Thus these findings
are consistent with the results of recent studies that have
indicated that PD-ECGF expression level is correlated
with the number of microvessels in various pathological
conditions and may contribute to neovascularization
[17,18,20,22-24]. Therefore, as many researchers, we
expect that PD-ECGF may become one of the major tar-
gets of angiogenesis therapy in future [44].
Conclusions
In this study, we have thought that loss of existing capil-
laries within the increased mesangial matrix might cause
hypoxia and thereby induce angiogenesis in acute and
chronic PAN. Our findings have suggested that acute
and chronic PAN causes progressively increased PD-
ECGF expression and induce the angiogenesis in the
glomeruli.
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